Search
Showing results for "1"
Great news for children living with type 1 diabetes following the recent Federal Government announcement of a new $6m training and education program to make it easier for teachers to support students with diabetes in schools.
Congratulations to Children's Diabetes Centre exercise researcher Dr Karen Rothacker for receiving the prestigious ADS President’s Clinical Young Investigator Award at the 2018 Australasian Diabetes Congress held in Adelaide recently.
Are you aged 18-40 years and living with T1D? If so, researchers planning a trial comparing different ways of providing diabetes education need feedback.
London Olympics torchbearer Gavin Griffiths is living proof that a Type 1 Diabetes diagnosis is no obstacle to making the most out of life.
Check out the Centre's video library here
A list of the Children's Diabetes Centre's research track record.
Citation: Libman I, Haynes A, Lyons S, Pradeep P, Rwagasor E, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and
Citation: MacDonald B, Burmaz M, Baker S, et al. TrialR: critical enablers and the need for reusable Rare Disease Clinical Trial infrastructure in
Citation: Sek K, Chen AXY, Cole T, Armitage JD, Tong J, ……… Waithman J, Parish IA, et al. Tumor site-directed A1R expression enhances CAR T cell
Rare diseases (RD) are conditions affecting fewer than 1 in 2000 persons, with over 7000 largely genetic RDs affecting 3.5 %-5.9 % of the global population, or approximately 262.9–446.2 million people. The substantial healthcare burden and costs, such as the $1 trillion annual expense in the USA, highlight the urgent need for improved RD management. The International Rare Diseases Research Consortium (IRDiRC) addresses this need through global collaboration, aiming for timely and accurate diagnosis, development of 1000 new therapies, and methodologies to measure impact by 2027.